Evaluation of the comparative effectiveness of Myleran and 6-MP in the management of patients with chronic myelocytic leukemia.
SHULLENBERGER
C C
CC
D002066:Busulfan / Q000628:therapy*; D019468:Disease Management; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D007951:Leukemia, Myeloid / Q000628:therapy*; D015122:Mercaptopurine / Q000628:therapy*
D015122:Mercaptopurine; D002066:Busulfan
BUSULFAN/therapy; LEUKEMIA, MYELOCYTIC/therapy; MERCAPTOPURINE/therapy